Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Longitudinal Stripping Massage vs. Percussion Device for Neck Pain: Ultrasound Study.

14 juni 2026 uppdaterad av: Dawid Łochyński, Poznan University of Physical Education

The Effect of Percussion Therapy on Neck Functional Disability, Pain and Upper Trapezius Muscle Properties Assessed by Elastography and Doppler Ultrasound in Patients With Neck Pain.

This study evaluates whether a single session of percussion therapy can reduce muscle tension and increase blood flow in the transverse cervical artery in individuals with neck pain. The investigators will evaluate muscle stiffness using ultrasound elastography, and assess blood flow in the transverse cervical artery via Doppler imaging before and after treatment. The primary objective is to determine how this therapy affects neck muscle relaxation and vascular responses, specifically within the upper trapezius region.

Studieöversikt

Status

Rekrytering

Betingelser

Intervention / Behandling

Studietyp

Interventionell

Inskrivning (Beräknad)

35

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

  • Polen
      • Poznan, Polen, 61-871
        • Rekrytering
        • Poznań University of Physical Education
        • Kontakt:

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Vuxen

Tar emot friska volontärer

Nej

Beskrivning

Inclusion Criteria:

  • Age: 18-60 years
  • Neck pain persisting for at least 3 months
  • Visual Analog Scale (VAS) score between 3 and 7
  • Neck Disability Index (NDI) between 30% and 48%

Exclusion Criteria:

  • Pregnancy and postpartum period
  • History of cervical spine or shoulder surgery
  • Diagnosed fibromyalgia, radiculopathy, or myelopathy
  • Myofascial therapy within the last 3 months
  • Use of analgesic medication within 48 hours before assessment
  • Venous diseases

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Randomiserad
  • Interventionsmodell: Crossover tilldelning
  • Maskning: Enda

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Percussion Therapy Arm
Subjects receiving percussion therapy using a massage device. Theragun device applied to dominant side of upper trapezius muscle. Session duration: 3 minutes.
Enhet: Percussion Therapy
Theragun device applied to dominant side of upper trapezius muscle. Session duration: 3 minutes.
Experimentell: Longitudinal Stripping Massage Arm
Subjects receiving manual longitudinal stripping massage. Longitudinal stripping massage of dominant side of upper trapezius muscle. Session duration: 3 minutes.
Övrig: Longitudinal stripping masage
Longitudinal stripping massage of dominant side of upper trapezius muscle. Session duration: 3 minutes.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Neck pain intensity on Visual Analog Scale (VAS)
Tidsram: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
Neck pain intensity evaluated using a Visual Analog Scale slide scale (score range 0-10, where 0 = no pain and 10 = worst imaginable pain). The patient marks their pain level using the slider, and the result is recorded as a numerical score. Unit of Measure: points
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Neck pain-related disability on Neck Disability Index (NDI)
Tidsram: Baseline, 2 days post-therapy (follow-up), immediately before next therapy session, and 2 days post-second therapy (final follow-up)
Neck pain-related disability measured with the Neck Disability Index (score range 0-50 points, where higher scores indicate greater disability). Unit of Measure: points
Baseline, 2 days post-therapy (follow-up), immediately before next therapy session, and 2 days post-second therapy (final follow-up)
Shear-wave elastography of upper trapezius muscle: mean stiffness
Tidsram: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
Ultrasound shear-wave elastography of the upper trapezius muscle at the midpoint (foramen magnum-acromion line) to evaluate the mean stiffness value. Measurements performed supine with head stabilized, arms alongside body, cervical spine neutral. Probe placed at the midpoint of the trapezius. Ultrasound gel applied for optimal contact. The measurement is performed 3 times and the average value is used; repeated if discrepancies. Same researcher throughout. Unit of Measure: kilopascals (kPa)
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
Myotonometry of upper trapezius muscle: oscillation frequency
Tidsram: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
Assessment of myofascial tissue tone (oscillation frequency) of the upper trapezius at the midpoint (foramen magnum-acromion line) using MyotonPRO device. Measurements performed supine with head stabilized, arms alongside body, cervical spine neutral. Probe placed perpendicular to the muscle surface at the midpoint of the trapezius. Same researcher throughout. Unit of Measure: hertz (Hz)
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
Myotonometry of upper trapezius muscle: dynamic stiffness
Tidsram: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
Assessment of biomechanical properties (dynamic stiffness) of the upper trapezius at the midpoint (foramen magnum-acromion line) using MyotonPRO device. Measurements performed supine with head stabilized, arms alongside body, cervical spine neutral. Probe placed perpendicular to the muscle surface at the midpoint of the trapezius. Same researcher throughout. Unit of Measure: newtons per meter (N/m)
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
Myotonometry of upper trapezius muscle: decrement
Tidsram: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
Assessment of viscoelastic properties (logarithmic decrement of oscillation, reflecting elasticity) of the upper trapezius at the midpoint (foramen magnum-acromion line) using MyotonPRO device. Measurements performed supine with head stabilized, arms alongside body, cervical spine neutral. Probe placed perpendicular to the muscle surface at the midpoint of the trapezius. Same researcher throughout. Unit of Measure: dimensionless
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
Active cervical range of motion: flexion
Tidsram: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
Active cervical range of motion (flexion) measured using EasyAngle goniometer mounted on the patient's head with an elastic band. The patient is seated upright with feet flat on the floor, head in neutral position. The movement is performed 3 times from neutral (goniometer recalibrated to 0° between trials) and the mean value is recorded. All measurements performed by the same researcher. Unit of Measure: degrees
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
Active cervical range of motion: extension
Tidsram: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)

Active cervical range of motion (extension) measured using EasyAngle goniometer mounted on the patient's head with an elastic band. The patient is seated upright with feet flat on the floor, head in neutral position. The movement is performed 3 times from neutral (goniometer recalibrated to 0° between trials) and the mean value is recorded. All measurements performed by the same researcher.

Unit of Measure: degrees
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
Active cervical range of motion: right lateral flexion
Tidsram: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
Active cervical range of motion (right lateral flexion) measured using EasyAngle goniometer mounted on the patient's head with an elastic band. The patient is seated upright with feet flat on the floor, head in neutral position. The movement is performed 3 times from neutral (goniometer recalibrated to 0° between trials) and the mean value is recorded. All measurements performed by the same researcher. Unit of Measure: degrees
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
Active cervical range of motion: left lateral flexion
Tidsram: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
Active cervical range of motion (left lateral flexion) measured using EasyAngle goniometer mounted on the patient's head with an elastic band. The patient is seated upright with feet flat on the floor, head in neutral position. The movement is performed 3 times from neutral (goniometer recalibrated to 0° between trials) and the mean value is recorded. All measurements performed by the same researcher. Unit of Measure: degrees
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
Active cervical range of motion: right rotation
Tidsram: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
Active cervical range of motion (right rotation) measured using EasyAngle goniometer mounted on the patient's head with an elastic band. The patient is seated upright with feet flat on the floor, head in neutral position. The movement is performed 3 times from neutral (goniometer recalibrated to 0° between trials) and the mean value is recorded. All measurements performed by the same researcher. Unit of Measure: degrees
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
Active cervical range of motion: left rotation
Tidsram: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
Active cervical range of motion (left rotation) measured using EasyAngle goniometer mounted on the patient's head with an elastic band. The patient is seated upright with feet flat on the floor, head in neutral position. The movement is performed 3 times from neutral (goniometer recalibrated to 0° between trials) and the mean value is recorded. All measurements performed by the same researcher. Unit of Measure: degrees
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)

Andra resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Peak systolic velocity (Vs) of the transverse cervical artery.
Tidsram: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)

Doppler ultrasound of the transverse cervical artery to evaluate Vs. Measurements performed supine with head stabilized, arms alongside body, cervical spine neutral. Probe positioned over the transverse cervical artery. Ultrasound gel applied for optimal contact. The measurement is performed 3 times and the mean value is used; repeated if discrepancies. Same researcher throughout.

Unit of Measure: millimeters per second (mm/s)
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
End-diastolic velocity (Vd) of the transverse cervical artery.
Tidsram: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)

Doppler ultrasound of the transverse cervical artery to evaluate Vd. Measurements performed supine with head stabilized, arms alongside body, cervical spine neutral. Probe positioned over the transverse cervical artery. Ultrasound gel applied for optimal contact. The measurement is performed 3 times and the mean value is used; repeated if discrepancies. Same researcher throughout.

• Unit of Measure: millimeters per second (mm/s)
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
Resistive index (RI) of the transverse cervical artery.
Tidsram: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)

Doppler ultrasound of the transverse cervical artery to evaluate RI. Measurements performed supine with head stabilized, arms alongside body, cervical spine neutral. Probe positioned over the transverse cervical artery. Ultrasound gel applied for optimal contact. The measurement is performed 3 times and the mean value is used; repeated if discrepancies. Same researcher throughout.

• Unit of Measure: dimensionless (lub ratio / score)
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Sponsor

Poznan University of Physical Education

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Beräknad)

1 juni 2026

Primärt slutförande (Beräknad)

1 juni 2028

Avslutad studie (Beräknad)

1 juni 2029

Studieregistreringsdatum

Först inskickad

1 juni 2026

Först inskickad som uppfyllde QC-kriterierna

1 juni 2026

Första postat (Faktisk)

5 juni 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

17 juni 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

14 juni 2026

Senast verifierad

1 juni 2026

Mer information

Termer relaterade till denna studie

Nyckelord

Ytterligare relevanta MeSH-villkor

Andra studie-ID-nummer

  • 667/21

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

IPD-planbeskrivning

Individual participant data will not be shared to protect patient privacy and confidentiality in accordance with GDPR regulations and local bioethics committee guidelines.

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera